A strong preference for the TA/TA dinucleotide step discovered for an acridine-based, potent antitumor dsDNA...

Area of Science:

• Structural biology
• Medicinal chemistry
• Molecular pharmacology

Background:

• Triazoloacridinone C-1305 is a potent antitumor agent with high efficacy against colon carcinomas.
• C-1305 is a known double-stranded DNA (dsDNA) intercalator, but its precise binding mode remains uncharacterized.

Purpose of the Study:

• To elucidate the three-dimensional (3D) structure and binding mode of the non-covalent adducts formed between C-1305 and dsDNA.
• To determine the sequence specificity of C-1305 binding to dsDNA.

Main Methods:

• Nuclear Magnetic Resonance (NMR)-driven and Molecular Dynamics (MD)-refined reconstruction of dsDNA:C-1305 adducts.
• NMR-based studies using various DNA duplexes to assess sequence-specific interactions.

Main Results:

• The ligand C-1305 intercalates into dsDNA at the TA/TA site, forming 1:1 complexes.
• Proton-proton Nuclear Overhauser Effect (NOE) contacts confirmed the ligand's orientation within the DNA binding site.
• C-1305 exhibits a strong preference for TA/TA and TG/CA dinucleotide steps, with no observed interaction with AT/AT, GG/CC, or GA/TC steps.

Conclusions:

• The study provides the first detailed 3D structural insights into C-1305 binding to dsDNA, revealing intercalation at TA/TA sites.
• The identified sequence specificity is critical for understanding C-1305's antitumor activity and guiding future drug design and clinical applications.